Premier Diagnostics v. Invitae Corporation

2023 ME 1, 288 A.3d 791
CourtSupreme Judicial Court of Maine
DecidedJanuary 5, 2023
DocketSom-22-26
StatusPublished
Cited by1 cases

This text of 2023 ME 1 (Premier Diagnostics v. Invitae Corporation) is published on Counsel Stack Legal Research, covering Supreme Judicial Court of Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Premier Diagnostics v. Invitae Corporation, 2023 ME 1, 288 A.3d 791 (Me. 2023).

Opinion

MAINE SUPREME JUDICIAL COURT Reporter of Decisions Decision: 2023 ME 1 Docket: Som-22-26 Argued: October 5, 2022 Decided: January 5, 2023

Panel: STANFILL, C.J., and MEAD, JABAR, HORTON, CONNORS, and LAWRENCE, JJ.

PREMIER DIAGNOSTICS

v.

INVITAE CORPORATION

STANFILL, C.J.

[¶1] Premier Diagnostics appeals from an order of the Superior Court

(Somerset County, Mullen, C.J.) dismissing its complaint for lack of personal

jurisdiction over the defendant, Invitae Corporation. Because we conclude that

Maine has personal jurisdiction over Invitae in this case, we vacate the

judgment of dismissal.

I. BACKGROUND

[¶2] The following facts, which we construe in Premier’s favor, are

contained in the parties’ pleadings and affidavits. See Fore, LLC v. Benoit, 2012

ME 1, ¶ 10, 34 A.3d 1125. 2

[¶3] Premier is a Delaware limited liability company, and its principal

place of business is in Madison, Maine. As such, Premier is a Maine resident.1

Kelly Hall is a member and the only employee of Premier; she also resides in

Madison. A significant element of Premier’s business is to use Hall to introduce

pharmacogenetic testing services (PGx testing) to healthcare organizations and

match them with laboratories who provide PGx testing.

[¶4] Invitae is a Delaware corporation with its principal place of business

in California. It is a leading national provider of medical genetic testing

services. It asserts it is not registered to do business in Maine, has no registered

agent in Maine, and does not own any real or personal property in Maine. Of its

2,555 employees, six are located in Maine and work from home. In 2020,

Invitae made $1,194,409 in sales to customers in Maine, representing less than

one-half of one percent of its total sales for that period. Premier does not argue

that these contacts with Maine are sufficient, without more, to confer personal

jurisdiction over Invitae.

1For purposes of personal jurisdiction, a limited liability company is a resident or citizen of the state under whose laws it is organized and of the state where it has its principal place of business. See Daimler AG v. Bauman, 571 U.S. 117, 137 (2014) (explaining that a corporation is “at home” in the state where it is incorporated and the state where it has its principal place of business); Frank v. PNK (Lake Charles) LLC, 947 F.3d 331, 337 n.10 (5th Cir. 2020) (noting that many courts apply the same “at home” test used for corporations to LLCs). Thus, Premier is a citizen of both Delaware and Maine. 3

[¶5] In June 2019, Hall was working with a healthcare system in Florida,

Baptist Health (Baptist), to match it with a new PGx testing laboratory. Around

the same time, Hall started networking with a PGx testing laboratory called

Genelex. Hall corresponded with Genelex and its chief executive officer,

Chris Howlett, for several months during 2019, discussing the benefits that

Genelex could provide to her client, Baptist. After some time, the Genelex team

represented to Hall that if she could broker a deal between Genelex and Baptist,

she would be Genelex’s designated “point person” on the Baptist account. As

the point person on the account, Hall would have a host of responsibilities,

including onboarding, regular evaluation, monitoring, and consulting. Genelex

formalized this representation in a letter of intent, emailed to Hall around

August 21, 2019, offering to engage Premier as a consultant on various Genelex

PGx accounts, including the Baptist account.

[¶6] In September and October 2019, Hall spent considerable time

cultivating the relationship between Genelex and Baptist. Eventually, Baptist

informed Hall that it had decided to partner with Genelex based on her

recommendation and efforts. For the next six months, Hall worked nearly full

time to finalize the Genelex-Baptist agreement. 4

[¶7] In January 2020, Howlett emailed Hall a proposed consulting

services agreement (CSA) between Premier and Genelex; the CSA included a

statement of work for the Baptist account. Hall signed and returned the

agreement about a month later. Thereafter, Hall continued to work diligently

to finalize the deal between Baptist and Genelex. Hall did so at Genelex’s

request, even though Genelex had not yet signed the CSA.

[¶8] In March 2020, with the CSA still only partially executed, Invitae

announced that it had entered into an agreement to acquire Genelex.2 For

purposes of this appeal, Invitae concedes that Genelex was thereafter acting as

its agent. On March 11, 2020, Hall emailed Howlett from her office in Maine to

ask whether the acquisition would impact their pending contract and whether

Premier should “explore relationships with other PGx testing labs.” In

response, Howlett emailed Hall a fully executed copy of the CSA and informed

her “that Invitae had confirmed that its acquisition of Genelex would have no

impact on the relationship, or contract, between Genelex and Premier

Diagnostics.”

[¶9] Baptist and Genelex then executed an agreement under which

Genelex would provide PGx testing for Baptist. Baptist’s decision to move

2 Invitae officially acquired a one hundred percent ownership interest in Genelex on April 1, 2020. 5

forward with the deal was “a direct result” of Hall’s efforts on behalf of Premier

and Genelex’s “assurances that the Invitae transaction would have no impact

on the relationship with Premier.” Thereafter, Hall contacted Howlett multiple

times to determine when her onboarding and orientation would occur as

provided in the CSA. Howlett responded that his time working with Premier

was limited by the Invitae acquisition, and her onboarding could not be

scheduled. Genelex never onboarded Hall.

[¶10] On May 27, 2020, Hall learned from Baptist that Invitae was

excluding her from onboarding meetings with Baptist by instructing Genelex to

hold the meetings using Invitae employees instead of Hall and Premier. The

next day, Invitae instructed Genelex to terminate the CSA.

[¶11] The complaint alleges that Invitae, through Genelex, fraudulently

misrepresented to Hall that the acquisition by Invitae would not impact

Premier and Genelex’s agreements; fraudulently induced Premier to continue

to work to finalize the Baptist deal; instructed Genelex to hold onboarding

meetings with Baptist and exclude Premier from that process; and pressured

and instructed Genelex to terminate the CSA after Baptist had finalized the

agreement with Genelex. Premier alleges it suffered significant economic

damages as a result of Invitae’s conduct. 6

[¶12] Based on these allegations, Premier asserted a claim of tortious

interference with contractual and advantageous economic relations against

Invitae, as Genelex’s principal.3 Invitae moved to dismiss the complaint on the

ground that Maine lacked personal jurisdiction over Invitae. The court agreed

and dismissed the complaint.4 The court's order was based on the pleadings,

exhibits, and affidavits only; it did not hold an evidentiary hearing. Premier

filed a timely appeal.

II. DISCUSSION

[¶13] “The term ‘personal jurisdiction’ refers to a court’s power to bring

a person into its adjudicative process.” Fore, 2012 ME 1, ¶ 5, 34 A.3d 1125

Free access — add to your briefcase to read the full text and ask questions with AI

Related

John R. Luongo v. Micharel A. Luongo Jr.
2023 ME 75 (Supreme Judicial Court of Maine, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
2023 ME 1, 288 A.3d 791, Counsel Stack Legal Research, https://law.counselstack.com/opinion/premier-diagnostics-v-invitae-corporation-me-2023.